Prognostic value of pulmonary hypertension in ambulatory patients with non-ischemic dilated cardiomyopathy

Akihiro Hirashiki, Takahisa Kondo, Shiro Adachi, Yoshihisa Nakano, Shuzo Shimazu, Shinya Shimizu, Ryota Morimoto, Takahiro Okumura, Toyoaki Murohara

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)

Abstract

Background: Pulmonary hypertension (PH) because of left-sided heart disease carries a poor prognosis. We investigated whether non-ischemic dilated cardiomyopathy (DCM) with PH is associated with poor prognosis. Methods and Results: A total of 256 consecutive DCM patients were enrolled. We measured the ratio of the maximum first derivative of left ventricular pressure (LVdP/dtmax)/systolic blood pressure and pressure half-time (T1/2) as cardiac function. Patients were allocated to 2 groups on the basis of mean pulmonary arterial pressure (mPAP), namely DCM without PH group (mPAP <25 mmHg; n=225) and DCM with PH group (mPAP ≥25 mmHg; n=31). We followed all patients for a mean of 4.3 years for the occurrence of cardiac events, defined as cardiac death or hospitalization for worsening heart failure. Cardiac events were significantly more frequent in the DCM with PH group than in the DCM without PH group (P<0.001). Multivariate Cox regression analysis revealed that mPAP ≥25 mmHg and LV end-systolic volume index were significant independent risk factors for cardiac death. Incidence of cardiac death was significantly higher in patients with DCM with PH than in those without PH [hazard ratio 11.79 (3.18-43.7), P<0.0001]. Conclusions: The presence of PH was independently associated with an increased incidence of cardiac death in ambulatory patients with DCM.

Original languageEnglish
Pages (from-to)1245-1253
Number of pages9
JournalCirculation Journal
Volume78
Issue number5
DOIs
Publication statusPublished - 2014
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Prognostic value of pulmonary hypertension in ambulatory patients with non-ischemic dilated cardiomyopathy'. Together they form a unique fingerprint.

Cite this